Hiroko Machida
Overview
Explore the profile of Hiroko Machida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
1317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mikami M, Tanabe K, Imanishi T, Ikeda M, Hirasawa T, Yasaka M, et al.
Sci Rep
. 2024 Aug;
14(1):20000.
PMID: 39198565
Epithelial ovarian cancer (EOC) is widely recognized as the most lethal gynecological malignancy; however, its early-stage detection remains a considerable clinical challenge. To address this, we have introduced a new...
2.
Yokoi A, Machida H, Shimada M, Matsuo K, Shigeta S, Furukawa S, et al.
Gynecol Oncol
. 2024 Aug;
190:42-52.
PMID: 39142091
Objective: To examine the efficacy and safety of minimally invasive surgery (MIS) and conventional abdominal surgery for epithelial ovarian cancer (EOC), stratified by treatment type. Methods: A systematic review and...
3.
Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer
Matsuo K, Shimada M, Matsuzaki S, Machida H, Shigeta S, Yoshida H, et al.
Int J Gynecol Cancer
. 2024 Aug;
34(9):1349-1358.
PMID: 39107048
Objective: The objective of this study was to assess the oncologic outcome of surgically-treated patients with early-stage, intermediate-risk cervical cancer according to postoperative therapy modality. Methods: This retrospective cohort study...
4.
Kameda S, Ichikawa T, Kawada S, Nagafuji Y, Togawa K, Ishii M, et al.
Tokai J Exp Clin Med
. 2024 Jun;
49(2):63-66.
PMID: 38904236
The isolated absence of the azygos vein was incidentally found on computed tomography (CT) examination in a 60-year-old female. The exact anomaly can be evaluated on high-resolution images of 0.4-mm...
5.
Matsuo K, Chen L, Klar M, Lee M, Machida H, Mikami M, et al.
Gynecol Oncol
. 2024 May;
187:37-45.
PMID: 38713997
Objective: To assess the prognostic performance of the 2023 International Federation of Gynecology and Obstetrics (FIGO) endometrial cancer staging schema. Methods: This retrospective cohort study queried the Commission-on-Cancer's National Cancer...
6.
Kakuwa T, Watanabe T, Niino M, Kawata A, Satoh T, Matsumura N, et al.
J Obstet Gynaecol Res
. 2024 May;
50(7):1182-1191.
PMID: 38697202
Aim: Quality of care is important to reduce disease progression, and improve both survival and quality of life. The Japan Society of Gynecologic Oncology has published treatment guidelines to promote...
7.
Machida H, Matsuo K, Higashi T, Aoki D, Enomoto T, Okamoto A, et al.
J Gynecol Oncol
. 2024 Mar;
35(5):e61.
PMID: 38456587
Objective: Hospital treatment volume affects survival in patients with endometrial cancer; notably, initial treatment at high-volume centers improves survival outcomes. Our study assessed the effect of hospital treatment volume on...
8.
Yoshida H, Matsuo K, Machida H, Matsuzaki S, Maeda M, Terai Y, et al.
Int J Gynecol Cancer
. 2024 Feb;
34(4):510-518.
PMID: 38316444
Objective: To examine the association between intrauterine manipulator use and pathological factors and oncologic outcomes in patients with endometrial cancer who had laparoscopic hysterectomy in Japan. Methods: This was a...
9.
Matsuo K, Matsuzaki S, Maeda M, Rau A, Yoshihara K, Tamura R, et al.
JAMA Netw Open
. 2023 Jun;
6(6):e2318602.
PMID: 37326992
Importance: Randomized clinical trials examining the effectiveness of neoadjuvant chemotherapy (NACT) for advanced ovarian cancer predominantly included patients with high-grade serous carcinomas. The use and outcomes of NACT in less...
10.
Matsuo K, Rau A, Machida H, Roman L, Wright J
Eur J Obstet Gynecol Reprod Biol
. 2023 Mar;
284:200-202.
PMID: 36948943
No abstract available.